1
|
Yan X, Luo C, Yang J, Wang Z, Shao Y, Wang P, Yang S, Li Y, Dai Q, Li W, Yang X, Tao H, Ren S, Li Z, Guo X, Li S, Zhu W, Luo Y, Li J, Li S, Cao R, Zhong W. Antiviral Activity of Selective Estrogen Receptor Modulators against Severe Fever with Thrombocytopenia Syndrome Virus In Vitro and In Vivo. Viruses 2024; 16:1332. [PMID: 39205306 PMCID: PMC11360069 DOI: 10.3390/v16081332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2024] [Revised: 08/17/2024] [Accepted: 08/19/2024] [Indexed: 09/04/2024] Open
Abstract
Severe fever with thrombocytopenia syndrome virus (SFTSV), also known as the Dabie Banda virus, is an emerging tick-borne Bunyavirus that causes severe fever with thrombocytopenia syndrome (SFTS). Currently, symptomatic treatment and antiviral therapy with ribavirin and favipiravir are used in clinical management. However, their therapeutical efficacy is hardly satisfactory in patients with high viral load. In this study, we explored the antiviral effects of selective estrogen receptor modulators (SERMs) on SFTSV infection and the antiviral mechanisms of a representative SERM, bazedoxifene acetate (BZA). Our data show that SERMs potently inhibited SFTSV-induced cytopathic effect (CPE), the proliferation of infectious viral particles, and viral RNA replication and that BZA effectively protected mice from lethal viral challenge. The mode of action analysis reveals that BZA exerts antiviral effects during the post-entry stage of SFTSV infection. The transcriptome analysis reveals that GRASLND and CYP1A1 were upregulated, while TMEM45B and TXNIP were downregulated. Our findings suggest that SERMs have the potential to be used in the treatment of SFTSV infection.
Collapse
Affiliation(s)
- Xintong Yan
- School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China; (X.Y.); (J.Y.); (P.W.); (S.R.); (J.L.)
- Song Li’s Academician Workstation, School of Pharmaceutical Sciences, Hainan University, Yazhou Bay, Sanya 572000, China
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; (Z.W.); (S.Y.); (Y.L.); (Q.D.); (W.L.); (X.Y.); (H.T.); (Z.L.); (X.G.); (S.L.); (W.Z.)
| | - Chongda Luo
- School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China; (X.Y.); (J.Y.); (P.W.); (S.R.); (J.L.)
- Song Li’s Academician Workstation, School of Pharmaceutical Sciences, Hainan University, Yazhou Bay, Sanya 572000, China
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; (Z.W.); (S.Y.); (Y.L.); (Q.D.); (W.L.); (X.Y.); (H.T.); (Z.L.); (X.G.); (S.L.); (W.Z.)
| | - Jingjing Yang
- School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China; (X.Y.); (J.Y.); (P.W.); (S.R.); (J.L.)
- Song Li’s Academician Workstation, School of Pharmaceutical Sciences, Hainan University, Yazhou Bay, Sanya 572000, China
| | - Zhuang Wang
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; (Z.W.); (S.Y.); (Y.L.); (Q.D.); (W.L.); (X.Y.); (H.T.); (Z.L.); (X.G.); (S.L.); (W.Z.)
| | - Yunfeng Shao
- School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China; (X.Y.); (J.Y.); (P.W.); (S.R.); (J.L.)
- Song Li’s Academician Workstation, School of Pharmaceutical Sciences, Hainan University, Yazhou Bay, Sanya 572000, China
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; (Z.W.); (S.Y.); (Y.L.); (Q.D.); (W.L.); (X.Y.); (H.T.); (Z.L.); (X.G.); (S.L.); (W.Z.)
| | - Ping Wang
- School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China; (X.Y.); (J.Y.); (P.W.); (S.R.); (J.L.)
- Song Li’s Academician Workstation, School of Pharmaceutical Sciences, Hainan University, Yazhou Bay, Sanya 572000, China
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; (Z.W.); (S.Y.); (Y.L.); (Q.D.); (W.L.); (X.Y.); (H.T.); (Z.L.); (X.G.); (S.L.); (W.Z.)
| | - Shaokang Yang
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; (Z.W.); (S.Y.); (Y.L.); (Q.D.); (W.L.); (X.Y.); (H.T.); (Z.L.); (X.G.); (S.L.); (W.Z.)
| | - Yuexiang Li
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; (Z.W.); (S.Y.); (Y.L.); (Q.D.); (W.L.); (X.Y.); (H.T.); (Z.L.); (X.G.); (S.L.); (W.Z.)
| | - Qingsong Dai
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; (Z.W.); (S.Y.); (Y.L.); (Q.D.); (W.L.); (X.Y.); (H.T.); (Z.L.); (X.G.); (S.L.); (W.Z.)
| | - Wei Li
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; (Z.W.); (S.Y.); (Y.L.); (Q.D.); (W.L.); (X.Y.); (H.T.); (Z.L.); (X.G.); (S.L.); (W.Z.)
| | - Xiaotong Yang
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; (Z.W.); (S.Y.); (Y.L.); (Q.D.); (W.L.); (X.Y.); (H.T.); (Z.L.); (X.G.); (S.L.); (W.Z.)
| | - Huimin Tao
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; (Z.W.); (S.Y.); (Y.L.); (Q.D.); (W.L.); (X.Y.); (H.T.); (Z.L.); (X.G.); (S.L.); (W.Z.)
| | - Sichen Ren
- School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China; (X.Y.); (J.Y.); (P.W.); (S.R.); (J.L.)
- Song Li’s Academician Workstation, School of Pharmaceutical Sciences, Hainan University, Yazhou Bay, Sanya 572000, China
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; (Z.W.); (S.Y.); (Y.L.); (Q.D.); (W.L.); (X.Y.); (H.T.); (Z.L.); (X.G.); (S.L.); (W.Z.)
| | - Zhenyang Li
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; (Z.W.); (S.Y.); (Y.L.); (Q.D.); (W.L.); (X.Y.); (H.T.); (Z.L.); (X.G.); (S.L.); (W.Z.)
| | - Xiaojia Guo
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; (Z.W.); (S.Y.); (Y.L.); (Q.D.); (W.L.); (X.Y.); (H.T.); (Z.L.); (X.G.); (S.L.); (W.Z.)
| | - Siqi Li
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; (Z.W.); (S.Y.); (Y.L.); (Q.D.); (W.L.); (X.Y.); (H.T.); (Z.L.); (X.G.); (S.L.); (W.Z.)
| | - Weiyan Zhu
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; (Z.W.); (S.Y.); (Y.L.); (Q.D.); (W.L.); (X.Y.); (H.T.); (Z.L.); (X.G.); (S.L.); (W.Z.)
| | - Yan Luo
- School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China; (X.Y.); (J.Y.); (P.W.); (S.R.); (J.L.)
- Song Li’s Academician Workstation, School of Pharmaceutical Sciences, Hainan University, Yazhou Bay, Sanya 572000, China
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; (Z.W.); (S.Y.); (Y.L.); (Q.D.); (W.L.); (X.Y.); (H.T.); (Z.L.); (X.G.); (S.L.); (W.Z.)
| | - Jiazheng Li
- School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China; (X.Y.); (J.Y.); (P.W.); (S.R.); (J.L.)
- Song Li’s Academician Workstation, School of Pharmaceutical Sciences, Hainan University, Yazhou Bay, Sanya 572000, China
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; (Z.W.); (S.Y.); (Y.L.); (Q.D.); (W.L.); (X.Y.); (H.T.); (Z.L.); (X.G.); (S.L.); (W.Z.)
| | - Song Li
- School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China; (X.Y.); (J.Y.); (P.W.); (S.R.); (J.L.)
- Song Li’s Academician Workstation, School of Pharmaceutical Sciences, Hainan University, Yazhou Bay, Sanya 572000, China
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; (Z.W.); (S.Y.); (Y.L.); (Q.D.); (W.L.); (X.Y.); (H.T.); (Z.L.); (X.G.); (S.L.); (W.Z.)
| | - Ruiyuan Cao
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; (Z.W.); (S.Y.); (Y.L.); (Q.D.); (W.L.); (X.Y.); (H.T.); (Z.L.); (X.G.); (S.L.); (W.Z.)
| | - Wu Zhong
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; (Z.W.); (S.Y.); (Y.L.); (Q.D.); (W.L.); (X.Y.); (H.T.); (Z.L.); (X.G.); (S.L.); (W.Z.)
| |
Collapse
|
2
|
Vaddadi K, Gandikota C, Huang C, Liang Y, Liu L. Cellular microRNAs target SARS-CoV-2 spike protein and restrict viral replication. Am J Physiol Cell Physiol 2023; 325:C420-C428. [PMID: 37399496 PMCID: PMC10390048 DOI: 10.1152/ajpcell.00516.2022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2022] [Revised: 06/12/2023] [Accepted: 06/27/2023] [Indexed: 07/05/2023]
Abstract
MicroRNAs (miRNAs) regulate gene expression posttranscriptionally and are implicated in viral replication and host tropism. miRNAs can impact the viruses either by directly interacting with the viral genome or modulating host factors. Although many miRNAs have predicted binding sites in the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) viral RNA genome, little experimental validation has been done. We first identified 492 miRNAs that have binding site(s) on the spike (S) viral RNA by a bioinformatics prediction. We then validated the selected 39 miRNAs by examining S-protein levels after coexpressing the S-protein and a miRNA into the cells. Seven miRNAs were found to reduce the S-protein levels by more than 50%. Among them, miR-15a, miR-153, miR-298, miR-508, miR-1909, and miR-3130 also significantly reduced SARS-CoV-2 viral replication. SARS-CoV-2 infection decreased the expression levels of miR-298, miR-497, miR-508, miR-1909, and miR-3130, but had no significant effects on miR-15a and miR-153 levels. Intriguingly, the targeting sequences of these miRNAs on the S viral RNA showed sequence conservation among the variants of concern. Our results suggest that these miRNAs elicit effective antiviral defense against SARS-CoV-2 by modulating S-protein expression and are likely targeting all the variants. Thus, the data signify the therapeutic potential of miRNA-based therapy for SARS-CoV-2 infections.NEW & NOTEWORTHY MicroRNAs can impact viruses either by directly interacting with the virus genome or by modulating host factors. We identified that cellular miRNAs regulate effective antiviral defense against SARS-CoV-2 via modulating spike protein expression, which may offer a potential candidate for antiviral therapy.
Collapse
Affiliation(s)
- Kishore Vaddadi
- Oklahoma Center for Respiratory and Infectious Diseases, Oklahoma State University, Stillwater, Oklahoma, United States
- The Lundberg-Kienlen Lung Biology and Toxicology Laboratory, Department of Physiological Sciences, Oklahoma State University, Stillwater, Oklahoma, United States
| | - Chaitanya Gandikota
- Oklahoma Center for Respiratory and Infectious Diseases, Oklahoma State University, Stillwater, Oklahoma, United States
- The Lundberg-Kienlen Lung Biology and Toxicology Laboratory, Department of Physiological Sciences, Oklahoma State University, Stillwater, Oklahoma, United States
| | - Chaoqun Huang
- Oklahoma Center for Respiratory and Infectious Diseases, Oklahoma State University, Stillwater, Oklahoma, United States
- The Lundberg-Kienlen Lung Biology and Toxicology Laboratory, Department of Physiological Sciences, Oklahoma State University, Stillwater, Oklahoma, United States
| | - Yurong Liang
- Oklahoma Center for Respiratory and Infectious Diseases, Oklahoma State University, Stillwater, Oklahoma, United States
- The Lundberg-Kienlen Lung Biology and Toxicology Laboratory, Department of Physiological Sciences, Oklahoma State University, Stillwater, Oklahoma, United States
| | - Lin Liu
- Oklahoma Center for Respiratory and Infectious Diseases, Oklahoma State University, Stillwater, Oklahoma, United States
- The Lundberg-Kienlen Lung Biology and Toxicology Laboratory, Department of Physiological Sciences, Oklahoma State University, Stillwater, Oklahoma, United States
| |
Collapse
|